Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a $100 copayment for Outpatient Diagnostic Tests and Therapeutic 
Services and Supplies. You can find this information on page 73 of the Plan's 2022 Evidence of Coverage 
(EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that epidural steroid injections (ESI) will be considered medically reasonable and necessary 
when the following requirements are met: 
 
History, physical examination, and concordant radiological image-based diagnostic testing that supports one of 
the following: 
 
a. Lumbar, cervical or thoracic radiculopathy, radicular pain and/or neurogenic claudication due to disc 
herniation, osteophyte or osteophyte complexes, severe degenerative disc disease, producing foraminal or 
central spinal stenosis; OR 
b. Post-laminectomy syndrome; OR 
c. Acute herpes zoster associated pain; AND 
d. Radiculopathy, radicular pain and/or neurogenic claudication is severe enough to greatly impact quality of 
life or function. An objective pain scale or functional assessment must be performed at baseline (prior to 
interventions). The same scale* must be used at each follow-up for assessment of response.; AND 
e. Pain duration of at least four (4) weeks, and the inability to tolerate noninvasive conservative care or medical 
documentation of failure to respond to four (4) weeks of noninvasive conservative care or acute herpes zoster 
refractory to conservative management where a four (4) week wait is not required. 
 
You can find this information in Local Coverage Determination (LCD): Epidural Steroid Injections for Pain 
Management (L33906). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Medicare covers testing for the BRCA1 and BRCA2 genes for patients suspected of 
hereditary breast and/or ovarian cancer syndromes. To be eligible for Medicare coverage, the individual being 
tested must have signs or symptoms of breast cancer [invasive or ductal carcinoma in situ (DCIS)], ovarian 
cancer (including fallopian tube and primary peritoneal cancer), pancreatic cancer, or prostate cancer and meet 
certain diagnostic and family history criteria. These criteria include having a history of certain cancers with a 
known BRCA gene mutation in the family, diagnosis of ovarian cancer, diagnosis of breast cancer under the 
age of 45, or over with at least some relatives who have also had one of these cancers. You can find this 
information in the Local Coverage Determination (LCD): MolDX: BRCA1 and BRCA2 Genetic Testing 
(L36813). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that no more than two of the same socket inserts (L5654, L5655, L5656, L5658, L5661, L5665, 
L5673, L5679, L5681, L5683) are allowed per individual prosthesis at the same time. 
 
You can find this information in the Local Coverage Determination (LCD) Lower Limb Prostheses L33787. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes the 
requested item or service but is limited to every 5 years. You can find this information on pages 85-86 of the 
Plan's 2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that effective for services performed on or after September 29, 2008, the Centers for Medicare 
and Medicaid Services has determined that TIPs are not reasonable and necessary for the treatment of low back 
pain. Therefore, TIPs, which include procedures that employ the use of a radiofrequency energy source or 
electrothermal energy to apply or create heat and/or disruption within the disc for the treatment of low back 
pain, are noncovered. 
 
You can find this information in the National Coverage Determination (NCD) Thermal Intradiscal Procedures 
(TIPs) 150.11. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
The rules say that a second confirmatory diagnostic facet joint procedure is considered medically reasonable 
and necessary in patients who meet BOTH of the following criteria: 
 The patient meets the criteria for the first diagnostic procedure; AND 
 After the first diagnostic facet joint procedure, there must be a consistent positive response of at 
least 80% relief of primary (index) pain (with the duration of relief being consistent with the 
agent used). 
You can find this rule at Local Coverage Determination (LCD) L34892: Facet Joint Interventions for Pain 
Management (eff. 4/25/21). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that Erythropoiesis Stimulating Agents (ESA) treatment for anemia secondary to 
myelosuppressive anticancer chemotherapy in solid tumors, multiple myeloma, lymphoma, and lymphocytic 
leukemia is only reasonable and necessary under the following specified conditions: 
 
1. The hemoglobin level immediately prior to initiation or maintenance of ESA treatment is less than10 g/dL 
(or the hematocrit is less than 30%). 
 
2. The starting dose for ESA treatment is the recommended FDA label starting dose, no more than 150 U/kg/3 
times weekly for epoetin and 2.25 mcg/kg/1 time weekly for darbepoetin alpha. Equivalent doses may be given 
over other approved time periods. 
 
3. Maintenance of ESA therapy is the starting dose if the hemoglobin level remains below 10g/dL (or 
hematocrit is less than 30%) 4 weeks after initiation of therapy and the rise in hemoglobin is = 1g/dL 
(hematocrit = 3%); 
 
4. For patients whose hemoglobin rises less than 1g/dl (hematocrit rise less than 3%) compared to pretreatment 
baseline over 4 weeks of treatment and whose hemoglobin level remains less than 10g/dL after the 4 weeks of 
treatment (or the hematocrit is less than 30%), the recommended FDA label starting dose may be increased 
once by 25%. Continued use of the drug is not reasonable and necessary if the hemoglobin rises < 1g/dl 
(hematocrit rise less than 3%) compared to pretreatment baseline by 8 weeks of treatment. 
 
5. Continued administration of the drug is not reasonable and necessary if there is a rapid rise in hemoglobin 
greater than 1g/dl (hematocrit greater than 3%) over 2 weeks of treatment unless the hemoglobin remains 
below or subsequently falls to less than 10g/dL (or the hematocrit is less than 30%). Continuation and 
reinstitution of ESA therapy must include a dose reduction of 25% from the previously administered dose. 
 
6. ESA treatment duration for each course of chemotherapy includes the 8 weeks following the final dose of 
myelosuppressive chemotherapy in a chemotherapy regimen. 
 
You can find this information in National Coverage Determination (NCD): Erythropoiesis Stimulating Agents 
(ESAs) in Cancer and Related Neoplastic Conditions (110.21). 
 
 If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for specialty care outside of the Plan provider network when network providers are unavailable or 
inadequate to meet a member's medical needs. You can find this rule at 42 CFR Section 422.112(a)(3). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the plan must use their Primary Care Physician (PCP) 
to receive care from providers to get medical care and services. The only exceptions are emergencies, urgently 
needed care when the network is not available (generally, when the enrollee is out of the area), out-of-area 
dialysis services, and cases in which the Plan authorizes the use of out-of-network providers. You can find this 
information on page 30 of the Plan's 2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that vascular stenting of lower extremity arteries performed for clinically significant occlusive 
vascular disease will be considered medically reasonable and necessary for a patient under any of the following 
circumstances: 
 
    Primary therapy for common iliac artery stenosis and occlusions. 
    Primary therapy for external iliac artery stenoses and occlusions. 
    Primary therapy for femoral/popliteal arterial stenosis and occlusions. 
    Salvage therapy for common and external iliac arteries for a suboptimal or failed result from balloon dilation 
(e.g., persistent translesional gradient, residual diameter stenosis greater than 50%, or flow-limiting dissection). 
    Salvage therapy for femoral/popliteal arteries for a suboptimal or failed result from balloon dilation (e.g., 
persistent translesional gradient, residual diameter stenosis greater than 50%, or flow-limiting dissection). 
    Salvage therapy for tibial/peroneal arterial lesions for a suboptimal result from ballon dilation. 
 
You can find this information in the Local Coverage Determination (LCD) Vascular Stenting of Lower 
Extremity Arteries L33763. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Standard Written Order (SWO) must be communicated to the supplier before a claim is 
submitted. If the supplier bills for an item addressed in this policy without first receiving a completed SWO, 
the claim shall be denied as not reasonable and necessary. You can find this rule in the Local Coverage 
Determination (LCD) - Lower Limb Prostheses (L33787) - Effective January 1, 2020. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a $50 copayment for physician/practitioner services, including doctor's 
office visits (specialist). You can find this information on pages 4-39 to 4-44 of the Plan's 2021 Evidence of 
Coverage (EOC).  
 
The Plan contract also says that enrollees must pay a $175 copayment for radiological diagnostic services, not 
including x-rays. You can find this information on pages 4-29 to 4-32 of the Plans 2021 Evidence of Coverage 
(EOC). 
 
The Plan contract also says that enrollees must pay a 20% coinsurance for Medicare Part B prescription drugs. 
You can find this information on pages 4-26 to 4-27 of the Plans 2021 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 417.414. 
 
The rules state that effective for dates of service specified below, the Centers for Medicare & Medicaid 
Services (CMS) has determined that PILD will be covered by Medicare when provided in a clinical study under 
section 1862(a)(1)(E) of the Social Security Act (the Act) through Coverage with Evidence Development 
(CED) for beneficiaries with LSS who are enrolled in an approved clinical study. You can find this information 
in the Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-03, National 
Coverage Determination (NCD): Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal 
Stenosis (150.13). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare pays only for ambulance transport. Ambulance vehicles must be designed and 
equipped to meet certain requirements. The vehicle must have emergency warning lights, sirens, 
communications equipment, a stretcher, linens, emergency medical supplies, oxygen equipment and other life-
saving equipment. The vehicle also must be staffed with two people, one of whom is certified as an emergency 
medical technician. Medicare will not pay for transport by vehicles that do not meet these requirements. You 
can find this rule at 42 CFR Section 410.41(a). 
 
The rules say that plans may offer a supplemental benefit to provide transport not covered by original 
Medicare. The transport offered must be used only for the enrollee's health care needs, such as transport to the 
doctors office. The transport must be arranged or directly provided by the health plan. The transport may not 
be used for other than health-related purposes. You can find this rule in the Centers for Medicare and Medicaid 
Services, Internet Only Manual, Publication 100-16, Medicare Managed Care Manual, Chapter 4, Section 30.3. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers routine, non-ambulance transportation as a supplemental (extra) benefit. This benefit 
covers non-medical transportation for trips to recovery meetings and trips to obtain food resources, such as the 
grocery store and food bank. For all other destinations, non-medical transportation is covered only if it is 
determined that it is necessary for your health goals, aligned and listed in your Individualized Personal Care 
Plan, and approved in advance. These trips need to be requested 48 hours in advance. You can find this 
information on page 87 of the Plans 2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say 
that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to 
an enrollee on a per-service basis. You can find this rule at 42 CFR Section 422.2. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay a $250 copayment, or 100% of the charge if there is no prior authorization 
for non-emergency transport for ambulance services. You can find this information in Chapter 4 on page 64 of 
the Plan's 2022 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that medically necessary services are those that are reasonable and necessary for the diagnosis or 
treatment of an illness or injury. Medically necessary services include services to improve the functioning of a 
malformed body member. You can find this rule in the Social Security Act, Section 1862(a)(1)(A). 
 
The rules say that services that Proton Beam Therapy (PBT) is a technology for delivering conformal external 
beam radiation with positively charged atomic particles to a well-defined treatment volume. PBT is approved 
by the U.S. Food and Drug Administration. Due to its unique dose deposition characteristics, PBT can, in 
certain situations, deliver the prescribed target dose while giving a lower dose to normal tissues as compared to 
photon-based forms of external beam radiotherapy. 
 
Photon beams deposit their greatest amount of energy beneath the patient's surface with a gradual reduction in 
energy deposition along the beam path as photons pass through the target and then through an exit point out of 
the body. In contrast, the physical profile of a beam of proton particles allows for the majority of its energy to 
be deposited over a very narrow range of tissue at a depth largely determined by the energy of the proton beam. 
A proton beam deposits relatively less radiation energy upon entering the body compared to a photon beam. 
The energy deposition of the proton beam then rapidly increases over a narrow range of tissue at a desired 
depth to produce an intense dose distribution pattern called the Bragg peak. Beyond the Bragg peak, energy and 
dose deposition rapidly decrease, resulting in the absence of any significant exit dose deposited in normal tissue 
beyond the target. 
 
PBT can allow for radiation treatment plans that are highly conformal to the target volume. PBT planning 
defines the necessary field sizes, gantry angles and beam energies needed to achieve the desired radiation dose 
distribution. 
 
An assessment of patient suitability for PBT is an important step in the process of care. Changes in the density 
and composition of tissues in the path of the beam have much greater impact on the delivered dose for protons 
than photons. Tissue interfaces, especially those with large differences in electron density, can lead to larger or 
unacceptable dosimetric uncertainties in PBT for certain patients. You can find this rule in the Local Coverage 
Determination (LCD) Proton Beam Therapy L35075. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.